跳至主要内容
临床试验/NCT07361952
NCT07361952招募中不适用

Oral Versus Intravenous Fluid Therapy in the Emergency Department

Esbjerg Hospital - University Hospital of Southern Denmark3 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2025年10月3日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
250
试验地点
3
主要终点
Percentage of patients achieving the fluid volume prescribed during the first 48 hours in the emergency department

研究概览

简要总结

The goal of this randomized clinical feasibility trial is to determine whether oral fluid therapy can achieve prescribed fluid volumes as effectively as intravenous fluid therapy in adult patients admitted to the emergency department who require fluid treatment.

The main questions it aims to answer are:

Are patients receiving oral fluids equally likely to achieve the prescribed fluid volume compared with patients receiving intravenous fluids?

Is it feasible to conduct a randomized trial of oral versus intravenous fluid therapy in the emergency department, based on recruitment rate and protocol adherence?

Researchers will compare oral tap water administration with standard intravenous crystalloid therapy to assess whether oral fluids are non-inferior in achieving prescribed fluid volumes and to evaluate feasibility outcomes.

Participants will:

Be randomized to receive either oral tap water or intravenous crystalloid fluids during their stay in the emergency department

Receive a fluid volume and administration rate determined by the treating physician

Be monitored according to standard clinical practice during the emergency department stay

Have fluid intake, vital signs, and clinical outcomes recorded, with follow-up through routine health records up to 30 days after inclusion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or above
  • At least 1000 ml of crystalloid fluid therapy prescribed by the physician

排除标准

  • Altered mental state prohibiting oral fluid intake (Glasgow Coma Scale ≤ 12)
  • Pregnancy
  • Oral fluids contraindicated (e.g. bowel obstruction)
  • Severe hyponatremia (sodium <120 mEq/L)
  • Requiring treatment in the intensive care unit

研究组 & 干预措施

Intravenous fluids

Active Comparator

Participants randomized to receive IV crystalloid fluids during ED stay

干预措施: Intravenous fluids (Other)

Oral fluids

Experimental

Participants randomized to receive oral tap water during ED stay

干预措施: Oral fluids (Other)

结局指标

主要结局

Percentage of patients achieving the fluid volume prescribed during the first 48 hours in the emergency department

时间窗: From inclusion until end of participation. End of participation is defined as the timepoint of leaving the emergency department or after 48 hours, whichever happens first.

次要结局

  • Fluids received in the ED (ml)(From inclusion to end of participation (defined as ED stay or maximum of 48 hours), unless mentioned otherwise)
  • Fluids received in the ED after inclusion in the study (ml)(From inclusion to end of participation (defined as ED stay or maximum of 48 hours), unless mentioned otherwise)
  • Change in systolic and mean arterial pressure at 8 hours or discharge, whatever comes first.(8 hours or discharge, whatever comes first.)
  • Hospital-free days alive at 30 days (counting up to the day the patient deceased if applicable)(30 days)
  • Mortality at 30 days(30 days)
  • Number of hours with a peripheral intravenous catheter(From inclusion to end of participation (defined as ED stay or maximum of 48 hours), unless mentioned otherwise)

研究者

发起方
Esbjerg Hospital - University Hospital of Southern Denmark
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验